Mesa Air Group Reports December 2019 Operating Performance
PHOENIX, Jan. 13, 2020 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) today reported Mesa Airlines’ operating performance for December 2019.Mesa […]
Cyclerion announces IW-6463 phase 1 healthy volunteer study results that support further development for neurodegenerative diseases
– Results in 110 subjects demonstrate favorable safety, CNS pharmacokinetics, and evidence of target engagement –– Study underway in elderly subjects […]
The Lovesac Company Updates Outlook Ahead of Participation at the ICR Conference
STAMFORD, Conn., Jan. 13, 2020 (GLOBE NEWSWIRE) — The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”) today updated its […]
GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2019
CARLSBAD, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular […]
Autolus Therapeutics to provide outlook for 2020 at the 38th Annual J.P. Morgan Conference
LONDON, Jan. 13, 2020 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T […]
Giyani Accompanies SRK, Tetra Tech and Royal IHC on a Site Visit to its K.Hill Manganese Deposit in Botswana to Kick off Feasibility Study
Not for distribution to U.S. newswire services or for dissemination in the United StatesOAKVILLE, Ontario, Jan. 13, 2020 (GLOBE NEWSWIRE) […]
Premier Health Closes Acquisition of Livecare
Livecare is an established leader in the Canadian digital health spaceHave provided over 27,000 telemedicine visitsService over 500 independent active […]
Denny’s Corporation Releases Preliminary Financial Results for Fourth Quarter and Fiscal Year 2019
– Company Reiterates 2019 Guidance Expectations for Adjusted EBITDA* –SPARTANBURG, S.C., Jan. 13, 2020 (GLOBE NEWSWIRE) — Denny’s Corporation (NASDAQ: […]
Neovasc Inc. Investor Update
VANCOUVER, Jan. 13, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader […]
Replimune Provides 2019 Year End Corporate Update and Reviews Expected 2020 Milestones
RP1: Registration-directed randomized controlled Phase 2 clinical trial of RP1 in combination with cemiplimab-rwlc (Libtayo®) in cutaneous squamous cell carcinoma […]
